Analysis of Factors Associated With The Occurrence of Amniotic Fluid Entry in Patients Undergoing Caesarean Section

Launched by SECOND HOSPITAL OF SHANXI MEDICAL UNIVERSITY · May 19, 2025

Keywords

ClinConnect Summary

This clinical trial is studying a serious condition called Amniotic Fluid Embolism, which can occur during a cesarean section (C-section). Researchers want to understand the factors that lead to the entry of amniotic fluid into the bloodstream and how this affects the body’s immune response. They will compare certain blood markers in women who experience this fluid entry with those who do not, while also monitoring important health indicators like blood pressure and heart rate at various points during and after the surgery.

To participate in this study, women aged 20 to 50 who are scheduled for a C-section may be eligible, as long as they have no history of heart or lung diseases and can understand the study information. The trial is not yet recruiting participants, but once it begins, those who join can expect to have their blood drawn and monitored closely for any reactions. It’s important to note that all participants will need to give informed consent, ensuring they understand the study's purpose and procedures.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Approved consent and informed consent of the patient by the Ethics Committee of the Second Hospital of Shanxi Medical University;
• • ASA classification of I-III;
• • Age 20-50 years old;
• • No previous history of psychiatric diseases or psychotropic drugs;
• Exclusion Criteria:
• • Suffer from diseases of the cardiorespiratory system;
• • Those with communication difficulties who were unable to complete the screening questionnaire;